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Abstract  (188 words) 
 
The Collagen Toolkits are libraries of 56 and 57 triple-helical synthetic peptides spanning the 
length of the collagen II and collagen III helices.  These have been used in solid-phase binding 
assays to locate sites where collagen receptors and extracellular matrix components bind to 
collagens.  Truncation and substitution allowed exact binding sites to be identified, and 
corresponding minimal peptides to be synthesised for use in structural and functional studies. 
170 sites where over 30 proteins bind to collagen II have been mapped, providing firm 
conclusions about the amino acid distribution within such binding sites.  Protein binding to 
collagen II is not random, but displays a periodicity of about 28nm, with several prominent 
nodes where multiple proteins bind.  Notably, the vicinity of the collagenase-cleavage site in 
Toolkit peptide II-44 is highly promiscuous, binding over 20 different proteins.  This may 
reflect either the diverse chemistry of that locus or its diverse function, together with the 
interplay between regulatory binding partners.  Peptides derived from Toolkit studies have 
been used to determine atomic level resolution of interactions between collagen and several 





• The Collagen Toolkits (systematic synthetic peptide libraries spanning the COL 
domains of collagens II and III) simplify the mapping of receptor and other protein 
binding sites on the collagen triple helix. 
• Compilation of data from over 30 collagen-binding proteins reveals binding activity 
across the length of the mature collagen II triple-helical domain. 
• Binding activity is periodic, being concentrated in nodes with about 28nm spacing 
(corresponding to about 5 Toolkit peptides) across all the D-periods of collagen II. 
• Amino acids are not equally distributed between nodes and inert peptides; nodes are 
enriched in F, L, R and O, whilst non-binding peptides contain A, D, K, P and S in excess. 
• Synthetic peptides derived from the Toolkits underpin structural studies and provide 
ligands to manipulate cell and protein function, and will in future find application in 
tissue engineering and regenerative medicine. 
 
Introduction   4430 words (Summary to Acknowledgments) 
 
The human collagens are a family of 28 triple-helical proteins that form, collectively, the most 
abundant protein group in vertebrates.  Collagens contain a defining Gly-x-x’ repeating 
sequence essential for the assembly of a right-handed triple-helix (COL domain); lacking a 
sidechain, glycine (G) alone can occupy the axial position of the triple helix.  The x and x’ 
positions of the constituent a-chains often contain proline (P) and hydroxyproline (O), 
respectively, that support the left-handed polyproline helix II which is adopted by each strand 
of the collagen superhelix.  Ricard-Blum has reviewed the collagen family[1], illustrating for 
each member the location of its COL domains and of other structures occurring in the non-
helical regions of the molecule, and the diversity of their supramolecular organisation. 
 
The structural properties of the collagens are fundamental to the integrity of the extracellular 
matrix.  Most obviously, the major fibrillar collagens I, II and III provide tensile strength to 
skin, bone, tendon, cartilage and blood vessel wall.  To fulfil this seemingly inert mechanical 
role, collagen must offer specific interaction sites for other matrix components, which implies 
evolutionary diversification from the primordial collagen GPO repeat[2].  Collagens also 
contribute to the cellular niche, a nidus which offers the cell both anchorage and survival, and 
within which connective tissue cells fulfil their normal functions.  Such regulatory roles of 
collagen require engagement of diverse cell surface receptors[3], and the evolution of 
complex signatures within the primary Gxx’ sequence of the collagen a-chains in concert with 
the maintenance of triple helix stability.  A recent review[4] expands on much of the 
foregoing. 
 
Early methods of mapping binding sites for cells or proteins within the collagens were not 
straightforward.  Typically, purified collagens extracted from tissue would be fragmented 
using cyanogen bromide (CB), cleaving at Met (M) residues.  The resulting defined linear 
fragments (CB peptides) would be separated chromatographically, then, if sufficiently long to 
be thermally stable, reassembled as triple helices, and their capacity to bind target proteins 
established.  This reductive approach allowed protein binding to be mapped, but those sites 
containing M (e.g. some integrin sites and the von Willebrand factor (VWF) locus – see below) 
were disrupted and so not identifiable.  Barnes employed this method extensively 30 years 
ago to map platelet receptor binding to collagen[5,6].  Further progress towards exact binding 
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sites might use blocking antibodies and epitope mapping[7,8].  Alternatives included rotary 
shadowing, using transmission electron microscopy to locate target proteins bound to 
collagen monomers.  Unambiguous identification of the tropocollagen molecule orientation 
required a marker (e.g. the N-propeptide of collagen III, or a bound antibody)[9,10].  Rotary 
shadowing yielded relatively low-resolution data, but, unlike CB peptide mapping, could be 
applied to intact heterotrimeric species such as collagen I.   
 
Development of the Collagen Toolkits 
 
The synthesis of collagen-like peptides in several laboratories opened the way to rapid and 
independent verification of putative protein-binding sites[11,12].  The Barnes group 
pioneered this approach by addressing the platelet-reactivity of blood vessel wall collagens; 
having located an integrin a2b1-binding site in CB3 from the collagen I a1 chain, they went 
on to synthesise seven overlapping triple-helical peptides spanning 150 residues of primary 
sequence, and so located the sequence GFOGER as the minimal integrin-recognition motif.  
This strategy neglected the a2 chain, and its success depended upon binding activity being 
expressed by the a1 chain alone.  This peptide set was the prototype Toolkit, and 
identification of GFOGER led to the first integrin-ligand co-crystal (PDB: 1DZI), and by 
sequence homology, the location of several further integrin-binding GxOGER and related 
motifs.  This breakthrough guided others, notably the Höök group, who used asymmetric 
binding to three sites in chicken collagen I and recombinant human collagen III, visualised by 
rotary shadowing, to locate integrin binding motifs, and proved authenticity of these sites by 
synthesis of triple-helical peptides[13,14]. 
 
With Wellcome Trust funding, the synthesis of the systematic collagen III Toolkit commenced 
in 2003 and was completed after 18 months by Nicolas Raynal and Graham Knight.  Collagen 
III was selected first for its role in blood vessel wall and because it is homotrimeric, promoting 
authentic peptide self-assembly, not then feasible for the heterotrimeric collagens such as 
the other key vessel wall species, collagen I.  Toolkit peptides (TKPs) contained 27 residues 
from the sequence of the collagen III COL domain, starting at its N-terminus and advancing 
successively by 18 residues, allowing a 9-residue overlap between adjacent peptides.  Primary 
(guest) sequence was flanked on each side by 5 GPP (host) triplets with sufficient propensity 
to form triple helices to drive this overall conformation regardless of unfavourable guest 
sequence.  At each end, the peptide terminated with a GPC extension to allow crosslinking of 
peptides as desired (an elaboration required for platelet activation by the GPO polymer, 
collagen-related peptide, CRP-XL).  Thus, each TKP is 63 residues long.   
 
Collagen III is anomalous; alignment of the fibrillar collagens reveals that its COL domain 
protrudes by 9 and 6 extra residues beyond the N- and C-termini of the corresponding 1014 
residues of collagens I and II, so that it contains 1029 residues.  Hence, Toolkit III comprises 
57 peptides, and Toolkit II, completed a year later, 56 peptides.  With hindsight, we would 
have aligned the peptides in Toolkits II with those of Toolkit III by sequence homology rather 
than starting at the N-terminus of each of their COL domains.  The a1(II) chain enjoys 78.9% 
identity with a1(I) but rather less (65.5%) with a2(I), so that, unless the a2(I) chain is critically 
involved in binding, results obtained with Toolkit II are likely to apply to collagen I.  
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The Toolkit project was envisaged as essentially collaborative; whilst our focus remained on 
platelet surface collagen receptors beginning with integrin a2b1, peptides were distributed 
to colleagues in other laboratories to explore their own targets.  To date, we have mapped 
38 different proteins binding to collagen, several as yet unpublished.  Our approach has been 
to locate the TKP exhibiting highest binding of target protein in ELISA-like assays, check 
whether adjacent peptides showed activity which might reside in their 9-residue overlap, 
then to synthesise truncated peptides until activity was lost.  Next, an Alanine-scan of x and 
x’ residues within the [Gxx’]n minimal binding motif would identify the residues involved in 
binding, allowing short GPP- or GPO-flanked triple-helical ligands to be made which could be 
used in structural studies[15-21], or to manipulate the target protein in biological settings[22-
26]. 
 
This strategy has been applied to the major collagen receptors: the four collagen-binding 
integrins[17,27-31], the three known immune receptors[32-34], both discoidin domain 
receptors (DDRs)[35,36] and GPR56§.  Matrix proteins have also been investigated: VWF, 
SPARC, several matrix metalloproteinases (MMPs), fibronectin (FN), thrombospondin 1[26], 
small leucine-rich repeat proteins (SLRPs) including fibromodulin (FMOD)[37] and 
chondroadherin (CHAD)[38], multimerin 1§ and dermatopontin§.  In addition, three bacterial 
adhesins have been studied[39,40].   
 
Recently, the Baumann group reported a binding site for the thrombospondin-4 and -5, using 
a recombinant collagen II Toolkit, with its triple-helical structure stabilised by a viral foldon 
domain[41].  This elegant approach suffers some drawbacks, notably the absence of proline 
hydroxylation in the recombinant Toolkit.  Thus, it will necessarily fail to detect binding sites 
for which O is crucial, such as for VWF and the collagen-binding immune receptors, whilst 
others, such as the integrin a1b1, display reduced affinity for motifs lacking O, i.e., 
GFPGER[42].  This approach, however, readily allows the insertion of sequences of any length.  
A similar use of foldon-templated collagen fragments allowed Zwolanek et al to identify novel 
Gxx’GER integrin-binding motifs in collagen XXII[43].  Similarly, a recombinant collagen II 
Toolkit was used to probe human autoantibodies that may be causal in rheumatoid 
arthritis[44].   This library suffers from the same drawbacks as the foldon approach, lacking 
O, and as a consequence, the melting temperature of some members was quite low, limiting 
their application. 
 
Limitations of the Toolkit approach  
Whilst any binding site up to 9-residues will in principle be located using the Toolkits, longer 
binding sites that happen to span the overlap region will be disrupted and may be missed.  
Further, hypothetical composite binding sites comprising adjacent helices in a collagen fibre 
will not be identified using a random TKP coating in a solid phase ELISA-like assay.  We have 
restricted our focus to the 1014- or 1029-residue COL domains, excluding the contiguous non-
helical telopeptides and the more distal propeptides.  Our findings should be applicable to 
homologous motifs in other collagens, at present excluding the heterotrimeric collagens, 
although recent progress in this area has been made.  It should be noted that even some 
homotrimeric collagens, e.g. the fibrillar XXIV and XXVII, contain short interruptions to the 
Gxx’ repeat sequence, and it is not yet clear whether synthetic Toolkit peptides would 
properly reflect these anomalies without the support of the underpinning fibrous assembly.  
The inclusion of GPC terminal triplets in our Toolkits allows us to crosslink the peptides 
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specifically as required, but may result in spontaneous oxidation and limited disulphide bond-
mediated polymerisation of triple helices.  This may be a drawback in some settings, e.g. for 
use in kinetic binding studies, but has the unexpected advantage that immobilisation of 
peptides on plastic ELISA wells is increased by the presence of the GPC extensions, possibly 
by increasing their avidity for the hydrophobic surface.  This makes for more consistent 
coatings and binding activity[45]. 
 
Periodic distribution of sites across the collagens. 
Many target proteins bind several peptides across the Toolkits, and a compilation of 168 
binding sites mapped for 30 proteins on Toolkit II is shown in Figure 1.  Several conclusions 
can be drawn.  Most prominent, TKP II-44 supports the binding of two-thirds of proteins 
examined to date, most with relatively high affinity.  Competition between these species 
would be expected in vivo.  Some of these binding partners are known to be involved in either 
the assembly of collagen fibres or their proteolysis, whereas others may simply exploit the 
diverse chemistry of II-44, which displays a hydrophobic N-terminal tract and a charged or 
polar C-terminus, whilst a GPO triplet close to the cleavage site located in TKP II-43 may 
introduce flexibility[46] and further enhance binding opportunities for the native collagen.   
 
Binding activity appears periodic rather than uniformly-distributed across the tropocollagen 
molecule.  Fourier transform of the binding distribution suggests a periodicity of around 10 
TKPs, corresponding to a half-wave of about 26nm, or 0.42 D-periods, close to the reported 
length of the overlap region in Collagen II[47].  This might indicate that higher-order fibre 
structure dictates the evolution of binding activity in collagen.   
 
Orgel has proposed that the intrinsic twist of the tropocollagen molecules within each 
microfibril leads to the burial of much of D-periods 1, 2 and 3 within the assembled 
fibre[48,49].  However, one might expect collagen-binding proteins crucial for mature tissue 
function to have evolved to recognise motifs that are available on the fibre surface.  We have 
argued previously that concealment of crucial binding sites, for VWF and for integrin a2b1 
located in D1 to D3, for example, would render them unable to perform their essential roles 
in haemostasis[50].  The presence of binding nodes extending from D1 into D4 is at odds with 
crucial sites therein being inaccessible within the collagen fibre.  Just 4 of the 12 nodes 
discovered using the Toolkits lie within the D-period overlap that Orgel dubbed the “Master 
Control Region” where important binding sites were proposed to reside[48].  The number of 
proteins that bind each D-period does not differ greatly, although the promiscuity of TKP II-
44 skews the distribution of sites within D4.  Our findings may inform debate on the exposure 
of the D-periods on the surface of the collagen fibre. 
 
In contrast, sites utilised only in free tropocollagen molecules in situ, either prior to fibre 
assembly or released from fibres during collagen turnover, suffer from no such evolutionary 
constraints.  Such sites might include those at or close to both the GxKGHR crosslinking motifs 
(located at residues 87 and 930 of the COL domain, in D1 and D4 ), where regulatory proteins 
may operate prior to or during fibre assembly, and the collagenase cleavage site, where 
proteins may bind collagen fragments after hydrolysis. 
 
Which amino acids predominate in binding sites? 
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Comparison of the primary sequence of the 12 binding nodes and the 13 inert TKPs reveals 
significantly different compositions (Figure 2).  Of hydrophobic residues, F and L are more 
abundant in nodes, reflecting their crucial contribution to hydrophobic interactions that have 
been defined in the structural studies outlined below.  I, M, V and Y relatively sparse but 
equally-distributed.  The polar residues E, N, Q and T are also equally represented, whilst S is 
more abundant in inert peptides.  The imino acids, P and O, are more abundant in inert and 
node peptides, respectively.  Since O is almost confined to the collagens, a role in specific 
binding would be expected and is confirmed below.  Other charged residues show large 
differences, with D and K markedly under-represented in binding nodes, and R over-
represented.  It is not surprising that A occurs less frequently in binding peptides, its short 
sidechain, like those of D and S, not protruding far from the collagen helix, minimising binding 
opportunities.  These global conclusions are derived from the full 27-residue guest sequence, 
extending beyond the binding motifs themselves.  Local echoing of the binding residue 
properties may serve as a means of recruiting targets to the vicinity of the more specific motif, 
increasing the probability of productive interaction.   
 
Some interactions can be examined more precisely: crystallography of proteins in complex 
with peptides (short motifs identified using Toolkit assays outlined above) yields positive 
atomic-level data on key interactions, subject to the usual artefacts of crystallisation.  In 
contrast, alanine-scanning of such motifs generally yields negative data: loss of interaction 
through ala-substitution.  Both datasets are available in some cases allowing consensus to be 
reached (see Table 1).  However, amino acid substitution may alter peptide conformation, 
introducing a structural artefact.  For example, an O residue destabilises the endo-exo ring 
pucker of an adjacent P, introducing flexibility into the helix [46] which may be essential for 
candidate protein binding.  It follows that Ala-scanning at O may reduce binding, without O 
contributing directly.  In contrast, we have observed increased binding of both MMP-1 and 
MMP-13 to a truncated version of TKP II-44, close to the collagenase cleavage site, when E 
within its RGER motif was replaced with A[51,52].  It may be that structural effects, e.g. 
elimination of the E–R sidechain interaction[53] altering the effective diameter of the helix, 
improve contact with the MMP at the apposed hemopexin domain.  
 
Long side chains extending away from the axis of the helix dominate protein–TKP interactions, 
illustrated in Figure 3, which shows the structure (PDB: 1Q7D) of the free integrin-binding 
peptide[53], with F, E and R sidechains clearly resolved.  Thus, F occurs commonly within 
binding nodes, although under-represented in collagen with just 13 and 8 occurrences in 
collagens II and III.  Random codon usage in collagen genes would result in F occurring 21 
times.  R also occurs frequently in binding sites, whilst the similarly-abundant K has been 
located just once (see below).  E is required in integrin-binding GxOGER motifs, but we have 
observed only one other contribution of E to binding, in the FN-binding site (TKP II-44) that 
overlaps with the MMP cleavage site.  The over-occurrence of E in collagens II and III (53 and 
48 times) relative to F indicates an important role for E in collagen which appears unrelated 
to its binding activity.  This may reflect charge-stabilisation between adjacent a-chains and 
triple-helices in the collagen fibre. 
 
Hydrophobic interactions of collagen residues other than F frequently stabilise the binding of 
proteins.  Thus, L, V and M are key contributors to several interactions, such as with integrins, 
DDRs, VWF, SPARC, OSCAR (PDB: 5EIV) and with MMPs and fibronectin.  Two aromatic 
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residues, W and Y, form part of the apposed binding pocket in several proteins, with which 
collagen F in particular can interact.  The aliphatic stems of R may also contribute to such 
hydrophobic pockets[15].   
 
Integrins represent a special case, where the canonical E carboxylate anion of the GxOGER 
motif directly coordinates Mg2+ in the metal ion-dependent adhesion site of the collagen-
binding integrin I-domains, in a1-, a2-, a10- and a11b1.  This interaction is supplemented by 
the hydrophobic x residues in both the leading and middle strands of collagen which contact 
the surface of the I domain.  These hydrophobic residues determine overall affinity, with L 
and M able to complete relatively high-affinity motifs[30].  The hydrophobic stem of R in 
GROGER may assume the same function, although no crystal structure exists[29].  Ala-
substitution at x results in near-basal affinity for the resting integrin; GAOGER, naturally 
occurring in collagens II and III, becomes important only for the activated integrin[30].   
 
The collagen-binding immune receptors, Glycoprotein (GP) VI, LAIR1 and OSCAR, rely on the 
unique abundance of O residues within collagen for binding specificity.  Such tracts are found 
at the C-terminus, TKPs II-56 and III-57.  GPO polymers are sufficient for recognition by 
GPVI[54], and its subsequent activation provided higher-order structure is introduced into the 
collagen peptide, whilst LAIR1[55] and OSCAR[20,32] require a greater diversity, with OSCAR 
in particular requiring an F residue (PDB: 5EIV).  Although both GPVI and LAIR1 bind TKP III-
30 with high affinity, there is little overlap between the repertoire of Toolkit peptides 
recognised by the three receptors despite conservation of 3D structure and primary 
sequence. 
 
Specific Binding Nodes 
1. Integrin sites: GxOGER 
The integrin-binding GxOGER and related motifs occur at conserved loci across collagens I, II 
and III[30].  In Toolkit II, these occur at peptides 7 and 8, 28, with a low affinity site in 44.  
These motifs bind few other proteins, indicating the importance of the cell-integrin 
interaction.  Note that an atypical positive charge [27] on its surface prevents a10b1 from 
binding GROGER, present in collagens I and III, but not II.  These sites display selectivity for 
the different integrins, with a1- and a10b1 preferring GLOGEN, in collagen III, whilst a2- and 
a11b1 express higher affinity for GFOGER, in collagens I, II, IV and others[56].  There is only 
limited evidence for absolute specificity, but analysis in a cellular setting is confounded by the 
activation state of the integrin, which may override intrinsic selectivity. 
 
2. Crosslinking sites: GxKGHR 
The only observed lysine-containing binding motif within the Toolkits is GxKGHR, the key 
inter-helix crosslinking site.  In nature, covalent crosslinks can form through the condensation 
of a lysine aldehyde located within the telopeptide of an a-chain in one helix with a target 
lysine residue in a nearby helix COL domain[57] .  Thus, in the staggered assembly of the native 
collagen fibre, the N-telo-lysine aldehyde condenses with K-930, and the C-telo-lysine 
aldehyde with K-87.  The target GxKGHR motif (K-87) is found in the unique sequence of TKP 
II-5 and II-52 and, as a result of the 9-residue offset between Toolkits II and III, in the overlaps 
of TKP III-5/6 and III-52/53 (K-930).  The lysine complement of native collagens is at least 
partially hydroxylated[58], whereas we have included no sidechain modification other than O 
in the Toolkits.  This may account for the under-representation of K in the observed binding 
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sites, since it is plausible that hydroxylysine contributes to binding in nature although absent 
from our experiments.  Acetylation of K compromised binding of FMOD to GxKGHR 
motifs[37], suggesting that its natural covalent modification through hydroxylation or further 
derivatisation, e.g. glycosylation and glycation, may be disruptive.  On the other hand, Ala-
scanning of the unmodified GxKGHR motif abolished target molecule binding, showing both 
K and R to be key contributors to the interaction with FMOD.  Similarly, Gebauer et al found 
that substitution of K by P reduced binding of cartilage oligomeric protein (COMP or TSP-5) to 
a T4 foldon-guided peptide set containing GxKGHR[41].  No crystal complex between a target 
protein and a full KGHR-containing motif is yet available, which might elucidate the binding 
mechanism, although R-containing peptides have been shown both to bind and yield 
structures with HSP47[59,60].  Several molecules known to be involved in the regulation of 
collagen crosslinking have been shown to bind at, or close to, this motif, including FMOD and 
TSP-1, both of which may help recruit the lysyloxidase which effects the hydroxylation of the 
telopeptide lysine residues needed for crosslink formation.   
 
3. Collagenase site   G~LAGQRGIVGLOGQRGER 
This site, comprising much of TKP II-44, contains the unique collagenase cleavage site.  
Notably, II-44 differs in only two conserved residues from the corresponding tract of collagen 
a1(I), so Toolkit II results will likely apply to collagen I.  II-44 binds both collagenases 
investigated in detail, MMP-1 and MMP-13[51,52] along with many other molecules, 
including low-affinity interactions with the DDRs[61], FMOD[37] and TSP-1[26], whilst the 
GQRGER motif that interacts with the hemopexin domain of full-length MMP-13 is also a weak 
integrin-binding site.  Interestingly, the free hemopexin domain binds to both the N-terminal 
GLAGQR and the central GLOGQR tracts, established by ala-scanning[51], offering a second 
nearby locus for recruitment of MMP-13.  MMPs and FN each interact with a long tract of 
collagen at this locus, at least four triplets, so that all three a-chains are likely to be 
involved[52,62].  Data is summarised in Table 1.  A linear collagen peptide adds a strand to a 
b-sheet of FN, which might imply unwinding of helical collagen as FN binds[62].  Although a 
similar mechanism has been mooted for MMP-1 binding to this locus, crystallography shows 
only minor relaxation of the helix in an MMP-1–peptide complex[52].  Comparison with an 
FN-helical peptide complex is needed.  This marked overlap of binding motifs suggests that 
competition between FN and MMP-1 or MMP-13 for this site in collagens I and II would be 
inevitable.   
 
4 VWF A3 site: GxRGQOGVMGFO 
This site, recently reviewed by Chen and Lin[63], was identified as binding the VWF A3 
domain[64], along with SPARC[9,19] and DDRs 1 and 2[16,35,61].  It is found at TKP II-22 and 
III-23.  The DDRs and SPARC utilise only the last 2 triplets, as indicated by co-crystal structures 
with DDR2 DS domain (PDB: 2WUH) and with SPARC (PDB: 2V53), whilst VWF A3 also interacts 
with the preceding 2 triplets (PDB: 4DMU).  This preceding sequence may be required for DDR 
signalling.  Like the extended collagenase site, all three a-chains contribute to the interaction 
with A3.  Importantly, this site provided insight into the chain register of collagen I, since 
neither a1(I) nor a2(I) contain a complete A3-binding motif, and the likely composite site is 




Three collagen-binding adhesins have been studied.  CNE, an adhesin of S. equi equi, binds 
with highest affinity to TKP II-44, and also to TKP II-1.  CNE may compete with the host 
proteins that recognise II-44, such as FN, perhaps so contributing to the virulence of the 
pathogen by disrupting endothelial cell aVb3 interaction with FN[40].  In marked contrast, 
two other adhesins, Yersinia adhesin A[39] and S. pyogenes M3§ are promiscuous, binding 
many sites across both Toolkits.  The large number of peptides binding YadA allows statistical 
analysis of its binding propensity, which revealed a marked preference for hydrophobic 
residues, and for Pro and Hyp.  This lack of specificity across the Toolkits may indicate that 
non-selective collagen binding has a role in virulence, where escape from the bloodstream 
and sequestration within the host tissue may be more important, by allowing the pathogen 
to evade host immune defences, than the specific disruption of host tissue homeostasis 
proposed for CNE. 
 
Inter-D-period interactions.   
Several proteins have been observed to bind sites in different D-periods that prove to be 
aligned within the fibrillar collagen assembly.  For example, FMOD binds TKPs III-5 and III-
44[37], and TSP-1 binds II-5, II-20 and II-45[26].  Both FMOD and TSP-1 have a role in 
regulating fibre crosslinking (which involves K in the GxKGHR motif found in II-5 and III-5) and 
in fibre assembly.  It seems likely that one collagen helix provides a platform within a fibre 
from which these molecular chaperones can deliver the required activity to the site in the 
adjacent D-period.  As well as this functional role, such alignments may also permit co-
operative binding of the trimeric TSP-1.  Chondroadherin may perform a similar function, 
binding a single site, II-26, which aligns perfectly with the GxKGHR crosslinking site in II-52[38], 
shown in Figure 4.  This would imply simultaneous accessibility of the relevant sections of D2 
and D4. 
 
Forward Developments  
The identification of specific binding motifs within collagen has provided tools to manipulate 
cell function in research and other applications.  The Leitinger group used integrin and DDR-
specific peptides to probe integrin-mediated cell adhesion[23].  We used peptide-coated 
surfaces to characterise the determinants of thrombus deposition[24,25,65,66], a method 
being developed elsewhere for diagnostic applications[67,68].  The Garcia group exploited 
the integrin motif GFOGER as a surface coating for orthopaedic devices[69], whilst Koide 
discusses the use of collagen peptide-based biomaterials[70].  Bacterial collagens have 
enjoyed some popularity as alternatives to synthetic peptides, and Toolkit-derived motifs 
have been introduced into bacterial collagens with a view to producing materials for tissue 
engineering[71-73].  In this laboratory, we have used photochemical coupling of specific 
motifs to enhance the cell-reactivity of collagen scaffolds, a generic technique which could be 
applied to derivatise many organic substrates[74,75].   
 
The next big step in the field will be to map binding sites in heterotrimeric collagens.  
Hartgerink and colleagues have designed heterotrimeric peptides using charge-
complementarity to align the different  collagen strands correctly, to produce collagen I-like 
self-assembling peptides [76,77], an approach recently brought to fruition by Jalan[78].  The 
synthetic challenge this strategy presents is substantial, requiring at least three discrete 




We believe the Toolkit peptide-derived collagenous materials will find application in drug 




The Toolkit project owes much to the pioneering work of Michael Barnes, and to the 
dedication and perseverance of the peptide chemists, Graham Knight, Nicolas Raynal, Loraine 
Foley, Dominique Bihan, Jean-Daniel Malcor and Arkadiusz Bonna.  Samir Hamaia made a 
huge contribution through protein expression and the development of solid-phase binding 
measurement throughout.  Funding was provided by Wellcome Trust, Medical Research 
Council and British Heart Foundation. 
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Figure 1a shows the number of proteins found to bind to each peptide from Toolkit II.  30 
proteins recorded 170 “hits” across the 56 peptides of Toolkit II.  Those with 5 or more “hits” 
are shaded in red and provide the sequences to be analysed as described in the legend to 
Figure 2.  The location of D-periods is indicated below the x-axis, with the number of hits per 
D-period in brackets. 
Figure 1b shows the output of a Fourier transform (Sinc function) of the data in Figure 1a.  
The x-axis shows periodicity, where 1 unit = the length of one peptide.  The series converged 
as shown, indicating that the binding pattern was periodic, with a “wavelength” of 10.6 
peptides; r2 = 0.988.  This value corresponds to [10.6 x 18] residues (the incremental length 
of each Toolkit peptide), i.e. 191 residues, and in length to [300 x 191/1014] nanometres, 
since the COL domain is 300nm in length and contains 1014 residues.  Thus, nodes (half-





Figure 2 shows the numbers of each amino acid found in the x and x’ positions of the 12 
peptides that reach the node threshold of 5 binding proteins (red bars), and the 
corresponding information for the 13 peptides with no partners (blue bars).  Residues in 
excess in inert peptides are at the left of the figure, and in binding nodes at the right.  These 
data were used to set up contingency tables, allowing the distribution of amino acids to be 
compared between peptide sets; the distribution differed significantly (𝜒2 test, p = .003). 
 
Figure 3 
Figure 3 shows the structure of the free integrin-binding peptide, [GPO]2GFOGER[GPO]3, using 
PDB file 1Q7D[53].  The key amino acids, F, E and R, protrude into the environment away from 
the axis of the helix, and are readily available for interaction with the surface of the integrin I 
domain.  Long residues such as these are over-represented in the Toolkit peptides that 
interact with their binding partners.  Rendering was performed using EzMol[79]. 
 
Figure 4 
Figure 4 shows a simple model of the alignment of tropocollagen molecules and D-periods 
in a collagen fibre (above) and an expanded section (below) showing the perfect alignment 
of the sole CHAD-binding sequence in TKP II-26 (at the D2-D3 boundary) with the KGHR 
crosslinking motif in D4.  This proximity implies involvement of CHAD in regulating the 
crosslinking process.  For reference, the second KGHR motif shown in D1 lies about 40nm 
towards the N-terminus of the molecule.  The Figure was published in Matrix Biology[38] 




Table 1.  Peptide II-44 residues critical for binding to FN, MMP1 and MMP-13 
 
II-44            G~LAGQRGIVGLOGQRGERGFOGLOGPS 
FN (crystal contacts[62])             GQRGIVGLOGQRGERGFOGLOG 
FN (Ala-scan§)        GPQG~LAGQRGIVGLOGQRGER 
MMP-13 (Ala-scan[51])      GPQG~LAGQRGIVGLOGQRGER 
MMP-1 (Ala-scan[52])       GPQG~LAGQRGIVGLOGQRGER 
MMP-1 (crystal contacts[52])  GPOGPQG~LAGQRGIVGLOGQRGER 
 
Table 1 shows the residues found to be crucial for binding of FN and MMPs to collagen-
derived peptides.  Erat[62] used a linear peptide (sequence as indicated) to form a complex 
(PDB: 3EJH) with the 8-9FnI module pair, and found a series of interactions (highlighted 
turquoise) that stabilised the b-strand adopted by the peptide on the FN surface.  We used 
ala-scanning of a Toolkit-derived triple-helical peptide, including the collagenase cleavage 
site, and found the first Lx’GxR motif to be critical for the binding of full-length FN.  The same 
peptide set was used to test binding of MMP-1 and MMP-13, and similar residues were 
involved, highlighted in magenta.  Notably, some ala-substitutions of charged or polar 
residues enhanced binding, highlighted in yellow, perhaps for structural reasons discussed in 
the text.  This applied even to MMP-1 although the hemopexin domain that aligns with the 
RGER motif makes little contact with the peptide (PDB: 4AUO).  The MMP-1 co-crystal showed 
more extensive contacts, highlighted in turquoise, on both sides of the scissile G~L bond than 
were revealed by ala-scanning. 
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